Celltrion
068270.KS
#765
Rank
NZ$58.14 B
Marketcap
NZ$254.98
Share price
-1.09%
Change (1 day)
19.27%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Half-year Reports

Thumbnail Celltrion
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report